Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes. - Wikidata - awgldk - TriplyDB

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

http://www.wikidata.org/entity/Q37400821

about

Technology to optimize pediatric diabetes management and outcomes Closed-loop glucose control: psychological and behavioral considerations Current application of continuous glucose monitoring in the treatment of diabetes: pros and cons The Minimum Duration of Sensor Data From Which Glycemic Variability Can Be Consistently Assessed.Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial.Continuous Glucose Monitoring and Global Reimbursement: An Update.The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data.A clinical trial of the accuracy and treatment experience of the Dexcom G4 sensor (Dexcom G4 system) and Enlite sensor (guardian REAL-time system) tested simultaneously in ambulatory patients with type 1 diabetes Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes Baseline predictors of A1C reduction in adults using sensor-augmented pump therapy or multiple daily injection therapy: the STAR 3 experience Accuracy performance of the Medtronic NexSensor™ for 6 days in an inpatient setting using abdomen and buttocks insertion sites.Adherence challenges in the management of type 1 diabetes in adolescents: prevention and intervention.Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.Youth and parent measures of self-efficacy for continuous glucose monitoring: survey psychometric properties.Fitting dynamic models with forcing functions: application to continuous glucose monitoring in insulin therapy.Use of sensors in the treatment and follow-up of patients with diabetes mellitus.Salient characteristics of youth with type 1 diabetes initiating continuous glucose monitoring Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.Clinical performance of a low cost near infrared sensor for continuous glucose monitoring applied with subcutaneous microdialysis.Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy A randomized clinical trial to assess the efficacy and safety of real-time continuous glucose monitoring in the management of type 1 diabetes in young children aged 4 to <10 years.Adherence to glycemic monitoring in diabetes.HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Da Improved Accuracy of Continuous Glucose Monitoring Systems in Pediatric Patients with Diabetes Mellitus: Results from Two Studies.Pediatric use of insulin pump technology: a retrospective study of adverse events in children ages 1-12 years The role of continuous glucose monitoring in the care of children with type 1 diabetes.Feasibility of prolonged continuous glucose monitoring in toddlers with type 1 diabetes The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study.Incentivizing behaviour change to improve diabetes care.A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system.Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring.Psychological Reactions Associated With Continuous Glucose Monitoring in Youth.Influences on Technology Use and Efficacy in Type 1 Diabetes Is the masked continuous glucose monitoring system clinically useful for predicting hemoglobin A1C in type 1 diabetes?Practical considerations in the use of real-time continuous glucose monitoring alerts.Toward closing the loop: an update on insulin pumps and continuous glucose monitoring systems.Smart telemedicine support for continuous glucose monitoring: the embryo of a future global agent for diabetes care.Use of continuous glucose monitoring in children and adolescents (*).

P2860

Q27022145-6883CB4E-7C1D-4071-9C67-0FFC6CFA8E5B Q30424290-08FC0160-F07E-484C-B2CF-07F33B22DD52 Q30455250-0796D657-28CC-43F6-A242-4EE2CB2BD63D Q30827667-507C43FE-85C4-4841-8F9B-4720F4482AB0 Q33556781-4F9662C9-B5F8-4B59-A1E5-2A9E4A2F08A8 Q33786148-FCED156F-1E33-43BC-AE17-B36471011C94 Q33945186-475F4938-4DD3-4953-B521-44969E69E76B Q33954163-23FE42ED-A7D8-4B00-B27B-D8D4E632DEE6 Q34360913-A84F1294-0B82-4736-9771-2BAAD1C8C5E2 Q34718324-F7A95A4F-4256-4369-8871-1ED531CAA1C6 Q35006833-E4CF7578-A6E1-4A9C-B3CA-71ACC77927DD Q35076006-2A20673B-5538-4B89-9D82-C15851D4E05E Q35174936-1118122F-751D-4FF3-945D-474AF83EA6C6 Q35360823-F63F0A47-C665-4F13-80E5-EE508119E730 Q35428773-3D1E47B1-263F-4279-823E-3BFF88D61462 Q35447304-88EBDF3B-7B87-4EA7-B424-5DC7973BC889 Q35594010-979E4D54-35C3-4D8E-A17F-C370700E4EB0 Q35608590-08002267-7C28-4A65-B7B6-D0D764DE692A Q35619522-934B6B16-1ADA-4386-81D4-09F188CB839C Q35682325-3ADDD9A5-7823-4E8F-97D7-B1192AF0A215 Q35682802-8AC8206A-8C2B-4966-ABD8-B4EF751D600A Q35688182-70E98236-8ABE-4541-AD2A-A01223D8FFFB Q36158972-3C24CC4F-D99D-4F11-A4B6-C703484340F4 Q36159014-CFC00043-637C-4ACB-8187-982EAE3B64EA Q36475961-CC7458B7-DCB8-4CD6-84F6-706EB39EDEE5 Q36605691-9853295E-3B69-4C98-BB8F-6BC9A2299980 Q36777662-CE3992A4-94B7-45D7-A0EF-B2D01CBC98A1 Q36879509-F1554FE8-BFDB-4FEC-B490-DFB3D4F320D6 Q36942191-F7CC15FE-39EA-4C06-BB49-4A1F011345A2 Q36968348-FD733C11-4F62-485D-9627-8DB5A574E177 Q37079853-44AB1480-71CA-4DB0-BD26-35A285595340 Q37192444-C2CA5631-65AA-41F5-B5B8-8ACA96D3FC8E Q37288497-F5F60529-0621-4E31-83E9-9F8FB498A817 Q37288556-15DBB5BE-F2E9-4A4D-A37B-F52270B85BE8 Q37288564-DAE03D91-53F4-4ED2-A4D5-29A1EF56172E Q37718918-DC98D768-2F55-498A-99E9-AA3490D07785 Q37761749-08D219B3-C01E-41C5-ADAE-76D1E1461BA4 Q37781158-90C97C8E-78A6-4ED7-968F-DA0FC90A2412 Q37838028-863912E1-1D9A-4582-8C96-416C2B95F859 Q37979361-5C693D70-181F-4DEC-B4AF-BAF5DEB0AB4E

P2860

Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes.

http://www.wikidata.org/entity/Q37400821

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Factors predictive of use and ...... monitoring in type 1 diabetes.

@en

Factors predictive of use and ...... monitoring in type 1 diabetes.

@nl

type

label

Factors predictive of use and ...... monitoring in type 1 diabetes.

@en

Factors predictive of use and ...... monitoring in type 1 diabetes.

@nl

prefLabel

Factors predictive of use and ...... monitoring in type 1 diabetes.

@en

Factors predictive of use and ...... monitoring in type 1 diabetes.

@nl

P1433

Q37400821-357E7FBC-6DF0-4068-BB26-86D2103AC4B8

P1476

Q37400821-87DC6655-1D5C-40EF-BEC7-5B841EEA8FD0

P2093

Q37400821-3036837F-F675-4AC1-A9CE-D671854AFAA0

Q37400821-454384CF-3923-426C-BBEE-53561FD02BA4

Q37400821-63BDADD4-86D5-4AFF-8D0A-798A530A8093

Q37400821-7C316C88-2A89-46E3-8C2E-62906520FF66

Q37400821-8651C8DB-5CCE-451D-A8BC-479F1D653F89

Q37400821-87E60193-2187-44E5-843F-824FDE936236

Q37400821-8B271F1F-68CF-4453-80EE-127E79D645E9

Q37400821-A17C4724-B4CF-4170-83B9-190885B501E2

Q37400821-D61D4B41-B730-4E45-A3A3-160E42A7E03D

Q37400821-FE8C1E32-B5DE-4BF1-85B7-A170493031AA

P2860

Q37400821-0C167D02-3B3C-421B-AFAF-D5D7F0A0F6A0

Q37400821-34C78692-6F8A-478D-8D5C-76AE1B67C72B

Q37400821-4BAAABF1-61DB-423E-9E0E-020CA8343B45

Q37400821-5613B62F-BB59-4AA4-BA9A-B5B8E0905719

Q37400821-57B5F454-8A86-4A1E-A30F-151686D00799

Q37400821-66FBC53A-0E95-4716-95E9-6BC65AD6E780

Q37400821-689A6D5B-AC7F-4B13-87C0-B9BD2A302CCC

Q37400821-9C1E6EAE-A6FC-45B5-9FD1-ED0F22954BD5

Q37400821-A6D57783-8D54-4E22-97F1-2A2DCE9AB4FE

Q37400821-AFE8980F-8971-4071-B671-9F9741A15B3E

P304

Q37400821-948660E1-6E35-4A17-8BFB-36FB9A4A0E36

P31

Q37400821-E1C2349D-DC8A-403F-A9BC-DE19769FC175

P356

Q37400821-D8C6D97B-0821-40DD-849A-C858D6588D4D

P407

Q37400821-FCB14D17-0E07-4F03-86A6-687B31D857ED

P433

Q37400821-BE2EAAC5-705E-40E7-B14A-102DFE3D6EE9

P478

Q37400821-016B746E-CCA3-4DF7-AB87-4B0F89E29814

P50

Q37400821-2FEC274D-EA2A-481C-A8A8-835C4CC64065

Q37400821-35A48AB9-8DD7-4C20-B130-6DAF598DBD3D

Q37400821-7F40C49E-B97B-473D-9340-2CFF7E701B7C

Q37400821-CFA68072-DA2F-4524-92E2-87D63FD385CC

Q37400821-F74B7505-F7AD-45B1-BE40-84DBAB088B78

P577

Q37400821-54B93F9E-B15C-4175-AEF2-D7532C5F74B0

P698

Q37400821-3FE61762-446A-4CFF-AEA5-01C69EFB720A

P921

Q37400821-16BB35E4-6A80-4D8A-884D-D7AFE15A437A

Q37400821-605c6533-0dda-4067-a601-3363f128f4b8

Q37400821-E0C7F891-625C-43D5-B336-6A9B64DC8F9B

Q37400821-EEDFD509-7679-4242-9D60-87D9C0AEC2BC

P932

Q37400821-D94148A1-0AB4-462E-A87B-679D7128F892

P356

P1433

P1476

Factors predictive of use and ...... monitoring in type 1 diabetes.

@en

P2093

Bruce Buckingham

http://www.w3.org/2001/XMLSchema#string

Dongyuan Xing

http://www.w3.org/2001/XMLSchema#string

H Peter Chase

http://www.w3.org/2001/XMLSchema#string

Howard Wolpert

http://www.w3.org/2001/XMLSchema#string

Irl Hirsch

http://www.w3.org/2001/XMLSchema#string

Jennifer M Block

http://www.w3.org/2001/XMLSchema#string

Katrina J Ruedy

http://www.w3.org/2001/XMLSchema#string

Kellee Miller

http://www.w3.org/2001/XMLSchema#string

Kerry Milaszewski

http://www.w3.org/2001/XMLSchema#string

Roy W Beck

http://www.w3.org/2001/XMLSchema#string

P2860

Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002

Use of the DirecNet Applied Treatment Algorithm (DATA) for diabetes management with a real-time continuous glucose monitor (the FreeStyle Navigator).

A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education.

The barrier of hypoglycemia in diabetes.

The effect of continuous glucose monitoring in well-controlled type 1 diabetes

Is glycemic control improving in U.S. adults?

Assessment of diabetes-related distress.

Fear of hypoglycemia in children and adolescents with diabetes.

Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial.

JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods.

P304

1947-1953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC09-0889

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Jean M Lawrence

William V Tamborlane

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group

P577

2009-08-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19675206

http://www.w3.org/2001/XMLSchema#string

P921

type-1 diabetes

glucose monitoring

P932

2768196

http://www.w3.org/2001/XMLSchema#string